Aiba, T., Miyanaga, A., Sugawara, S., Watanabe, S., Matsumoto, M., Shoji, T., Shukuya, T., Okano, T., Tsubata, Y., Morita, S., Matsuyama, K., Kobayashi, K., Maemondo, M., Seike, M. (2026). Necitumumab plus pembrolizumab and chemotherapy for untreated advanced squamous NSCLC: Phase I/II NEJ048A/NEXUS.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8528